levamisole has been researched along with Blood Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Song, CC; Wen, LY | 1 |
Betzler, M; Heimpel, H; Herfarth, C; Lang, M; Lohrmann, HP; Schlag, P; Schreml, W | 1 |
Binet, JL; Le Porrier, M | 1 |
Gröhn, P; Heinonen, E; Holsti, L; Holsti, P; Klefström, P | 1 |
Bonnet, J; Carter, S; Costanzi, JJ; Dabich, L; Dixon, DO; Durie, BG; Files, JC; Rivkin, S; Salmon, SE; Stephens, R | 1 |
2 review(s) available for levamisole and Blood Diseases
Article | Year |
---|---|
[Toxic effects of levamisole].
Topics: Digestive System Diseases; Drug Eruptions; Female; Hematologic Diseases; Humans; Levamisole; Male; Nervous System Diseases; Urologic Diseases | 2000 |
[Hematology in 1975].
Topics: Acute Disease; Anemia, Aplastic; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Transplantation; Doxorubicin; Drug Therapy, Combination; Hematologic Diseases; Humans; Leukemia; Levamisole; Lymphocytes; Plicamycin; Radionuclide Imaging; Sarcoma | 1976 |
3 trial(s) available for levamisole and Blood Diseases
Article | Year |
---|---|
Adjuvant chemo(immuno-)-therapy of primary breast cancer with adriamycin-cyclophosphamide (and levamisole)--six-year evaluation.
Topics: Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Levamisole; Mastectomy; Neoplasm Recurrence, Local | 1983 |
Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Double-Blind Method; Female; Follow-Up Studies; Hematologic Diseases; Humans; Levamisole; Menopause; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Random Allocation | 1985 |
Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Hematologic Diseases; Humans; Levamisole; Melphalan; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Random Allocation; Vincristine | 1986 |
1 other study(ies) available for levamisole and Blood Diseases
Article | Year |
---|---|
Levamisole--a cautionary note.
Topics: Animals; Hematologic Diseases; Humans; Immunity, Cellular; Levamisole; Lung Neoplasms | 1979 |